ProfileGDS4718 / 207980_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 51% 55% 84% 61% 57% 40% 27% 57% 58% 63% 65% 69% 28% 36% 39% 50% 69% 31% 27% 36% 50% 65% 67% 56% 50% 37% 54% 25% 61% 20% 34% 39% 48% 59% 35% 44% 38% 55% 61% 76% 57% 18% 36% 34% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5819551
GSM549102patient 115, normal, homogenized [OPG study]5.8271755
GSM549104patient 119, normal, homogenized [OPG study]8.4570684
GSM549108patient 138, normal, homogenized [OPG study]6.1867461
GSM549119patient 077, normal, homogenized [OPG study]5.9124957
GSM549133patient 032, cancer, homogenized [OPG study]4.9313840
GSM549139patient 042, cancer, homogenized [OPG study]4.4057427
GSM549099patient 107, normal, homogenized [OPG study]5.89657
GSM549109patient 139, normal, homogenized [OPG study]6.0079658
GSM549110patient 046, normal, homogenized [OPG study]6.2970563
GSM549114patient 063, normal, homogenized [OPG study]6.4298165
GSM549122patient 082, normal, homogenized [OPG study]6.8351969
GSM549134patient 033, cancer, homogenized [OPG study]4.4681928
GSM549136patient 036, cancer, homogenized [OPG study]4.7367836
GSM549140patient 044, cancer, homogenized [OPG study]4.9170639
GSM549111patient 047, normal, homogenized [OPG study]5.4684650
GSM549113patient 057, normal, homogenized [OPG study]6.8193969
GSM549132patient 031, cancer, homogenized [OPG study]4.5591131
GSM549137patient 038, cancer, homogenized [OPG study]4.3961127
GSM549142patient 047, cancer, homogenized [OPG study]4.9113436
GSM549100patient 110, normal, homogenized [OPG study]5.5072950
GSM549107patient 135, normal, homogenized [OPG study]6.4719665
GSM549115patient 068, normal, homogenized [OPG study]6.5965367
GSM549116patient 072, normal, homogenized [OPG study]5.8791656
GSM549120patient 078, normal, homogenized [OPG study]5.4885650
GSM549131patient 030, cancer, homogenized [OPG study]4.7718137
GSM549118patient 074, normal, homogenized [OPG study]5.7675754
GSM549129patient 027, cancer, homogenized [OPG study]4.3627725
GSM549123patient 088, normal, homogenized [OPG study]6.1729461
GSM549124patient 006, cancer, homogenized [OPG study]4.200620
GSM549126patient 015, cancer, homogenized [OPG study]4.7151134
GSM549128patient 025, cancer, homogenized [OPG study]4.9297139
GSM549103patient 117, normal, homogenized [OPG study]5.4366148
GSM549117patient 073, normal, homogenized [OPG study]5.9993859
GSM549138patient 041, cancer, homogenized [OPG study]4.7383335
GSM549141patient 045, cancer, homogenized [OPG study]5.112344
GSM549130patient 028, cancer, homogenized [OPG study]4.8944138
GSM549101patient 111, normal, homogenized [OPG study]5.8076755
GSM549105patient 128, normal, homogenized [OPG study]6.2189561
GSM549106patient 134, normal, homogenized [OPG study]7.5417776
GSM549112patient 048, normal, homogenized [OPG study]5.8991357
GSM549125patient 011, cancer, homogenized [OPG study]4.0946618
GSM549127patient 024, cancer, homogenized [OPG study]4.7899136
GSM549135patient 035, cancer, homogenized [OPG study]4.6573334